pharmaceuticals: be expensive in canada

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents industry
Weight: 0.48
, environment
Weight: 0.28
Siblings banking industry
Weight: 0.32
, automobile industry
Weight: 0.32
, chemicals
Weight: 0.31
, electronics
Weight: 0.31
, semiconductor
Weight: 0.30

Related properties

Property Similarity
be expensive in canada 1.00
be cheaper in canada 0.96
cost less in canada 0.93
be expensive in australia 0.90
be expensive in usa 0.90
be more expensive in australia 0.89
be expensive in india 0.88
be more expensive in uk 0.87
be cheaper in usa 0.87
be cheaper in in uk 0.86

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.13
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.04
¬ Remarkable(electronics, be expensive in canada)
0.12
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.89
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.04
¬ Remarkable(electronics, be more expensive in australia)
0.11
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.87
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.04
¬ Remarkable(electronics, be cheaper in usa)
0.11
Rule weight: 0.13
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.11
¬ Remarkable(electronics, be expensive in australia)
0.11
Rule weight: 0.13
Evidence weight: 0.96
Similarity weight: 0.87
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.09
¬ Remarkable(electronics, be more expensive in uk)
0.11
Rule weight: 0.13
Evidence weight: 0.92
Similarity weight: 0.88
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.14
¬ Remarkable(electronics, be expensive in india)

Remarkability from sibling implausibility

0.60
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 1.00
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.04
Remarkable(electronics, be expensive in canada)
Evidence: 0.03
¬ Plausible(electronics, be expensive in canada)
0.54
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.90
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.11
Remarkable(electronics, be expensive in australia)
Evidence: 0.13
¬ Plausible(electronics, be expensive in australia)
0.53
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.89
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.04
Remarkable(electronics, be more expensive in australia)
Evidence: 0.04
¬ Plausible(electronics, be more expensive in australia)
0.52
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.87
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.04
Remarkable(electronics, be cheaper in usa)
Evidence: 0.04
¬ Plausible(electronics, be cheaper in usa)
0.52
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.87
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.09
Remarkable(electronics, be more expensive in uk)
Evidence: 0.07
¬ Plausible(electronics, be more expensive in uk)
0.52
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.88
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.14
Remarkable(electronics, be expensive in india)
Evidence: 0.19
¬ Plausible(electronics, be expensive in india)

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.94
¬ Salient(pharmaceuticals, be expensive in canada)

Similarity expansion

0.79
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.96
Evidence: 0.96
Typical(pharmaceuticals, be expensive in canada)
Evidence: 0.94
¬ Typical(pharmaceuticals, be cheaper in canada)
0.77
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.96
Evidence: 0.94
Salient(pharmaceuticals, be expensive in canada)
Evidence: 0.90
¬ Salient(pharmaceuticals, be cheaper in canada)
0.77
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.93
Evidence: 0.96
Typical(pharmaceuticals, be expensive in canada)
Evidence: 0.75
¬ Typical(pharmaceuticals, cost less in canada)
0.75
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.93
Evidence: 0.94
Salient(pharmaceuticals, be expensive in canada)
Evidence: 0.74
¬ Salient(pharmaceuticals, cost less in canada)
0.74
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.96
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.87
¬ Plausible(pharmaceuticals, be cheaper in canada)
0.74
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.90
Evidence: 0.96
Typical(pharmaceuticals, be expensive in canada)
Evidence: 0.87
¬ Typical(pharmaceuticals, be expensive in usa)
0.73
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.93
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.68
¬ Plausible(pharmaceuticals, cost less in canada)
0.72
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.94
Salient(pharmaceuticals, be expensive in canada)
Evidence: 0.90
¬ Salient(pharmaceuticals, be expensive in usa)
0.70
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.90
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.82
¬ Plausible(pharmaceuticals, be expensive in usa)
0.62
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.96
Evidence: 0.52
Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.50
¬ Remarkable(pharmaceuticals, be cheaper in canada)
0.58
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.93
Evidence: 0.52
Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.56
¬ Remarkable(pharmaceuticals, cost less in canada)
0.53
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.90
Evidence: 0.52
Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.64
¬ Remarkable(pharmaceuticals, be expensive in usa)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.94
Salient(pharmaceuticals, be expensive in canada)
Evidence: 0.96
¬ Typical(pharmaceuticals, be expensive in canada)
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)

Typical implies Plausible

0.43
Rule weight: 0.48
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.90
Plausible(pharmaceuticals, be expensive in canada)
Evidence: 0.96
¬ Typical(pharmaceuticals, be expensive in canada)

Typicality and Rermarkability incompatibility between siblings

0.12
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.25
¬ Typical(electronics, be expensive in canada)
0.10
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 0.89
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.27
¬ Typical(electronics, be more expensive in australia)
0.10
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 0.87
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.26
¬ Typical(electronics, be cheaper in usa)
0.10
Rule weight: 0.14
Evidence weight: 0.84
Similarity weight: 0.87
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.31
¬ Typical(electronics, be more expensive in uk)
0.09
Rule weight: 0.14
Evidence weight: 0.77
Similarity weight: 0.90
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.44
¬ Typical(electronics, be expensive in australia)
0.09
Rule weight: 0.14
Evidence weight: 0.74
Similarity weight: 0.88
Evidence: 0.52
¬ Remarkable(pharmaceuticals, be expensive in canada)
Evidence: 0.50
¬ Typical(electronics, be expensive in india)